| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $62M | ||
| $60M |
Buys | $94,113,089 | 30 | 100 |
Sells | $0 | 0 | 0 |
| BROADWOOD PARTNERS, L.P. | 10 percent owner | 30 | $94.11M | 0 | $0 | $94.11M |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Over the last 12 months, insiders at STAAR Surgical Company have bought $94.11M and sold $0 worth of STAAR Surgical Company stock.
On average, over the past 5 years, insiders at STAAR Surgical Company have bought $41.52M and sold $98.96M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $94.11M.
The last purchase of 27,485 shares for transaction amount of $606,138 was made by BROADWOOD PARTNERS, L.P. (10 percent owner) on 2026‑01‑09.
| 2026-01-09 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 27,485 0.0554% | $22.05 | $606,138 | -4.87% | ||
| 2026-01-08 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 3,240 0.0064% | $21.94 | $71,082 | -5.17% | ||
| 2026-01-07 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 66,467 0.1333% | $22.00 | $1.46M | -1.66% | ||
| 2026-01-06 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 336,946 0.6154% | $21.62 | $7.28M | +2.77% | ||
| 2025-11-21 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 797,486 1.605% | $27.86 | $22.22M | -14.95% | ||
| 2025-11-20 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 393,382 0.7895% | $27.14 | $10.68M | -12.61% | ||
| 2025-11-19 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 309,132 0.6245% | $26.42 | $8.17M | -9.47% | ||
| 2025-04-10 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 900 0.0017% | $15.18 | $13,658 | +52.94% | ||
| 2025-04-09 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 8,200 0.0155% | $15.08 | $123,676 | +49.50% | ||
| 2025-04-08 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 178,127 0.3428% | $15.32 | $2.73M | +56.98% | ||
| 2025-04-07 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 138,054 0.2707% | $15.61 | $2.16M | +46.53% | ||
| 2025-04-04 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 497,631 1.0082% | $15.91 | $7.92M | +48.18% | ||
| 2025-04-03 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 209,535 0.4142% | $16.97 | $3.56M | +35.23% | ||
| 2025-04-02 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 31,780 0.0638% | $17.43 | $553,925 | +33.69% | ||
| 2025-03-31 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 22,189 0.0445% | $17.46 | $387,360 | +33.30% | ||
| 2025-03-28 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 8,131 0.0162% | $17.47 | $142,014 | +31.96% | ||
| 2025-03-27 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 3,620 0.0073% | $17.48 | $63,294 | +33.41% | ||
| 2025-03-26 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 101,633 0.2052% | $17.50 | $1.78M | +33.21% | ||
| 2025-03-25 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 34,296 0.0695% | $17.44 | $598,177 | +33.89% | ||
| 2025-03-21 | BROADWOOD PARTNERS, L.P. | 10 percent owner | 102,400 0.2078% | $17.74 | $1.82M | +31.37% |
| BROADWOOD PARTNERS, L.P. | 10 percent owner | 15453629 31.257% | $324.06M | 168 | 28 | +8.7% |
| BAILEY DAVID | President, Int'l Operations | 1127800 2.2811% | $23.65M | 0 | 18 | |
| Caldwell Barry G | President and CEO | 251839 0.5094% | $5.28M | 4 | 1 | +5.27% |
| BAILEY DON M | director | 145139 0.2936% | $3.04M | 3 | 0 | +7% |
| CURTIS NICHOLAS T | Sr. VP Sales | 112990 0.2285% | $2.37M | 1 | 2 | <0.0001% |
| Mason Caren L | President & CEO | 83645 0.1692% | $1.75M | 1 | 10 | +1.38% |
| Blickensdoerfer Hans-Martin | Sr. VP, Comm. Ops, China | 77200 0.1561% | $1.62M | 0 | 12 | |
| DUFFY DONALD | director | 54000 0.1092% | $1.13M | 2 | 2 | +3.35% |
| MORRISON DAVID R | director | 40000 0.0809% | $838,800.00 | 0 | 4 | |
| Francese James E | Sr. VP, Comm. Ops., NA, APAC | 34908 0.0706% | $732,020.76 | 0 | 13 | |
| Kaufman Charles S | V.P. , General Counsel | 33500 0.0678% | $702,495.00 | 1 | 2 | <0.0001% |
| ANDREWS DEBORAH J | Chief Financial Officer | 31267 0.0632% | $655,668.99 | 0 | 20 | |
| Holliday Keith | Chief Technology Officer | 27633 0.0559% | $579,464.01 | 0 | 16 | |
| Gesten Samuel J | Chief Legal Officer | 27583 0.0558% | $578,415.51 | 0 | 10 | |
| Williams Patrick F. | Chief Financial Officer | 25619 0.0518% | $537,230.43 | 0 | 2 | |
| Kamijo Isamu | President, STAAR Japan Inc. | 23334 0.0472% | $489,313.98 | 0 | 1 | |
| Moore John C | director | 21387 0.0433% | $448,485.39 | 4 | 2 | +39.87% |
| LOGAN MARK B | director | 19600 0.0396% | $411,012.00 | 4 | 0 | +21.63% |
| Hughes Robin | Vice President, R&D | 19575 0.0396% | $410,487.75 | 2 | 10 | <0.0001% |
| MEIER RICHARD A | director | 18300 0.037% | $383,751.00 | 3 | 2 | +42.69% |
| Wall William P | director | 16235 0.0328% | $340,447.95 | 0 | 1 | |
| GOODMEN WILLIAM WALTER | Global VP, Human Resources | 15000 0.0303% | $314,550.00 | 0 | 6 | |
| Barnes Scott D | Chief Medical Officer | 11032 0.0223% | $231,341.04 | 0 | 1 | |
| WEISNER AIMEE S | director | 10864 0.022% | $227,818.08 | 2 | 0 | <0.0001% |
| SCHLOTTERBECK DAVID L | director | 10000 0.0202% | $209,700.00 | 1 | 0 | +47.13% |
| FAGEN DONALD L | V.P. Sales for N. America | 9300 0.0188% | $195,021.00 | 0 | 2 | |
| Hansen Graydon C. | Sr. VP, Global Operations | 8847 0.0179% | $185,521.59 | 0 | 6 | |
| Felberg Craig | VP, R&D and Clinical Affairs | 8700 0.0176% | $182,439.00 | 0 | 3 | |
| Hayashida Jon K. | VP, Global Clinical, Medical | 8342 0.0169% | $174,931.74 | 0 | 8 | |
| Todd Donald J | President, Asia/Pacific | 7500 0.0152% | $157,275.00 | 0 | 3 | |
| Butcher Arthur C | director | 4208 0.0085% | $88,241.76 | 1 | 0 | <0.0001% |
| SILVERMAN LOU | director | 2924 0.0059% | $61,316.28 | 1 | 2 | <0.0001% |
| Lin Elizabeth Yeu | director | 2855 0.0058% | $59,869.35 | 1 | 0 | <0.0001% |
| Zhou Lilian Yansheng | director | 2327 0.0047% | $48,797.19 | 1 | 0 | +11.37% |
| ROUSH JACK STEVEN | director | 1000 0.002% | $20,970.00 | 1 | 0 | <0.0001% |
| Increased Positions | 109 | +46.98% | 12M | +22.96% |
| Decreased Positions | 105 | -45.26% | 15M | -27.55% |
| New Positions | 64 | New | 10M | New |
| Sold Out Positions | 40 | Sold Out | 8M | Sold Out |
| Total Postitions | 236 | +1.72% | 51M | -4.59% |
| Broadwood Capital Inc | $319,060.00 | 27.04% | 13.52M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $171,311.00 | 14.52% | 7.26M | -112,193 | -1.52% | 2025-09-30 |
| Vanguard Group Inc | $100,751.00 | 8.54% | 4.27M | -121,644 | -2.77% | 2025-09-30 |
| Yunqi Capital Ltd | $59,001.00 | 5% | 2.5M | +88,773 | +3.68% | 2025-09-30 |
| State Street Corp | $45,098.00 | 3.82% | 1.91M | -91,941 | -4.59% | 2025-09-30 |
| Balyasny Asset Management L.P. | $42,799.00 | 3.63% | 1.81M | +2M | New | 2025-09-30 |
| Magnetar Financial Llc | $28,423.00 | 2.41% | 1.2M | +1M | New | 2025-09-30 |
| Geode Capital Management, Llc | $27,702.00 | 2.35% | 1.17M | -18,998 | -1.59% | 2025-09-30 |
| Goldman Sachs Group Inc | $23,040.00 | 1.95% | 976,259 | +794,020 | +435.7% | 2025-09-30 |
| Alpine Associates Management Inc. | $21,549.00 | 1.83% | 913,087 | +913,087 | New | 2025-09-30 |